Innovotech Inc
🇨🇦XTSX.IOTCanadaHealthcare
PriceCA$0.07-0.01 (-12.5%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 0
- Medium: 1
- Low: 0
Operating cash flow: crossed zero, from positive to negative
Free with a Finzer account.
Profile
- Healthcare
- Biotechnology
- Canada
Identity
- Exchange
- TSX Venture Exchange . XTSX
- Type
- Stock
- ISIN
- CA45772U1049
- CUSIP
- 45772U104
Company
- Employees
- 0
- Headquarters
- Edmonton, Canada
- Website
- https://innovotech.ca
Market
- Shares outstanding
- 54.4M
- Market cap
- CA$3.5M
Highlights
- Market cap
- CA$3.5M
- EPS LTM
- CA$0.01calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 13.18calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CA$3.62M+195.03%up year on year
- Net income
- CA$265.78K+172.92%up year on year
- Gross margin
- 48.33%-2.16%down year on year
- Free cash flow
- -CA$333.49K+6.81%up year on year
Latest news
News is not sourced for this exchange.
Business summary
Innovotech Inc is a company in the healthcare sector, listed on TSX Venture Exchange (Canada) under the ticker IOT. Its market capitalisation is CA$3.5M, from 54.4M shares outstanding, as of . Across the 246 trading sessions to the shares traded between CA$0.06 and CA$0.29, and the last close of CA$0.07 sits 4% of the way up that range. The company is headquartered in Edmonton, Canada.
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.